Brazil Pet Veterinary Diets Market Trends and Insights
Rising Chronic Disease Diagnosis in Dogs and Cats
The Brazil pet veterinary diet market is benefiting from a heavier chronic disease load across urban dogs and cats, which is turning more veterinary visits into longer treatment nutrition cycles. The 2025 peer-reviewed study, "Canine Obesity - Contributing Factors and Body Condition Evaluation" by Mariana T. Resende and co-authors, identified canine obesity as one of the most common nutritional disorders encountered in veterinary practice, underscoring the sustained need for weight-management formulas. A 2025 study based on records from the University of São Paulo veterinary hospital also showed that dietary intervention has become a routine part of managing metabolic disorders in dogs, confirming that food is now a regular therapeutic tool rather than an occasional add-on. These cases often progress into diabetes, renal disease, osteoarthritis, and digestive complications, and that gives prescribed nutrition a longer role across the animal’s life rather than a short recovery window. The same pattern is strengthening renal and urinary demand in cats, giving the Brazilian pet veterinary diets market a durable clinical base tied to repeat use rather than one-time diagnosis.Pet Humanization and Premium Health Spending
The Brazil pet veterinary diets market is also supported by a shift in how owners approach health spending for companion animals, particularly in large urban households where pets are treated as part of the family budget. This shift is reflected in stronger demand for condition-specific products, including renal, gastrointestinal, and weight management diets, as owners increasingly seek long-term dietary solutions rather than short-term interventions. Farmina Pet Foods Holding N.V. reported Brazil revenue growth of 25% to BRL 400 million (USD 74 million) in 2024, indicating that premium clinical nutrition can scale when owners accept higher spending as part of regular health management. Veterinary recommendations continue to play a central role in driving this acceptance, as clinic-based endorsements lend credibility to higher-priced therapeutic products and encourage repeat purchasing behavior. This spending pattern is positioning treatment diets within the preventive care conversation, helping the category capture value beyond acute disease episodes and supporting a more stable long-term revenue mix in the Brazil pet veterinary diets market.High Tax Burden and Premium Price Sensitivity
The Brazil pet veterinary diets market is still limited by the high final price of premium therapeutic food, and that price pressure is most visible when imported or premium-positioned products move outside top-income households. Brazil’s indirect tax structure raises shelf prices for clinically positioned diets, which narrows the addressable buyer pool and keeps many owners in a wait-and-see pattern even when veterinary advice is clear. This pressure has a direct competitive effect because domestic suppliers such as PremieRpet S.A. face fewer import-related burdens and can compete more aggressively on price while still holding a clinical positioning. At the same time, inflation and tighter disposable income conditions weaken the ability of lower-middle-income urban households to stay on prescribed food for the full treatment period. The result is that premium acceptance remains strongest at the top end of the market, while broader conversion in the Brazil pet veterinary diets market still depends on better affordability and sharper value communication.Other drivers and restraints analyzed in the detailed report include:
- Veterinarian-Led Prescription Influence
- Expansion of Specialty Retail and E-Commerce Access
- Income Inequality and Uneven Affordability Across Cities
Segment Analysis
Digestive sensitivity held 17.7% market share in 2025 and represented the largest sub-product in the Brazil pet veterinary diets market. The segment benefits from frequent cases of chronic enteropathies, inflammatory bowel disease, food intolerance, and fat absorption issues, all of which make nutritional management a central part of treatment rather than a secondary step. Farmina Pet Foods Holding N.V. reinforced this space in 2025 with the launch of Gastrointestinal UltraCare Low Fat Canine at the World Small Animal Veterinary Association congress in Rio de Janeiro, which was presented for the treatment of chronic diarrhea, inflammatory bowel disease, and exocrine pancreatic insufficiency in dogs. Renal and urinary tract disease products also hold a firm place because many feline renal and urinary cases remain on therapeutic food for long periods, and that keeps these sub-products close to the category’s most stable recurring demand.In Brazil, obesity diets are projected to expand at a 11.3% CAGR between 2026 and 2031, making it the fastest-growing subsegment of the Brazil pet veterinary diets industry. Premierpet S.A. launched its nutrição clínica úmidos line in 2025 and supported the installation of the first pet-specific dual-energy x-ray absorptiometry scanner in South America at the University of São Paulo, which strengthens obesity and metabolic disease research and gives the brand greater scientific visibility in this segment. Diabetes, oral care diets, derma diets, and other veterinary diets further broaden the therapeutic base, so the brazil pet veterinary diets industry is not dependent on a single condition cluster or breed pattern for growth.
Complete Report Scope:
- Sub Product
- Diabetes
- Renal
- Urinary Tract Disease
- Digestive Sensitivity
- Oral Care Diets
- Derma Diets
- Obesity Diets
- Other Veterinary Diets
- Pets
- Cats
- Dogs
- Other Pets
- Distribution Channel
- Convenience Stores
- Online Channel
- Specialty Stores
- Supermarkets/Hypermarkets
- Other Channels
List of Companies Covered in this Report:
- Mars, Incorporated
- Nestle S.A. (Purina PetCare Company)
- Virbac SA
- Zoetis Inc.
- PremieRpet S.A. (Grandfood Indústria e Comércio Ltda.)
- Adimax Indústria e Comércio de Alimentos Ltda
- Special Dog Company (Manfrim Industrial e Comercial Ltda.)
- Total Alimentos S.A.
- Farmina Pet Foods Holding N.V.
- BRF S.A.
- Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company)
- Archer-Daniels-Midland Company (ADM)
- Alltech, Inc.
- Dechra Pharmaceuticals PLC
- Affinity Petcare S.A.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Mars, Incorporated
- Nestle S.A. (Purina PetCare Company)
- Virbac SA
- Zoetis Inc.
- PremieRpet S.A. (Grandfood Indústria e Comércio Ltda.)
- Adimax Indústria e Comércio de Alimentos Ltda
- Special Dog Company (Manfrim Industrial e Comercial Ltda.)
- Total Alimentos S.A.
- Farmina Pet Foods Holding N.V.
- BRF S.A.
- Hill's Pet Nutrition, Inc. (Colgate-Palmolive Company)
- Archer-Daniels-Midland Company (ADM)
- Alltech, Inc.
- Dechra Pharmaceuticals PLC
- Affinity Petcare S.A.

